ROME IV FGIDs | Chapter 9: Esophageal Disorders

ROME IV FGIDs | Chapter 8: Biopsychosocial Aspects of FGIDs

ROME IV FGIDs | Chapter 10: Gastroduodenal Disorders

Knowles CH, Aziz Q. Basic and clinical aspects of gastrointestinal pain. Pain 2009;141:191-209.
Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465.
Galmiche JP, Zerbib F, des Varannes SB. Treatment of GORD: Three decades of progress and disappointments. United Eur Gastroenterol J 2013;1:140-150.
Ozaki N, Sengupta JN, Gebhart GF. Mechanosensitive properties of gastric vagal afferent fibers in the rat. J Neurophysiol 1999;82:2210-2220.
Botha C, Farmer AD, Nilsson M, et al. Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity. Gut 2015;64:611-617.
Knowles CH, Aziz Q. Visceral hypersensitivity in non-erosive reflux disease. Gut 2008;57:674-683.
Hollerbach S, Bulat R, May A, et al. Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP). Neurogastroenterol Motil 2000;12:555-565.
Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998;115:1363-1373.
Barish CF, Castell DO, Richter JE. Graded esophageal balloon distention. A new provocative test for noncardiac chest pain. Dig Dis Sci 1986;31:1292-1298.
Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago Classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012;24 Suppl 1:57-65.
Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013;108:679-692; quiz 693.
Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol 2007;293:G878-885.
Drossman DA. Rome III : the functional gastrointestinal disorders. McLean, VA: Degnon Associates, 2006.
Locke GR 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
Eslick GD. Noncardiac chest pain: epidemiology, natural history, health care seeking, and quality of life. Gastroenterol Clin North Am 2004;33:1-23.
Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting—a population-based study. Aliment Pharmacol Ther 2003;17:1115-1124.
Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: A population-based study. Aliment Pharmacol Ther 2003;18:595-604.
Kennedy JW, Killip T, Fisher LD, et al. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974–1979. The Coronary Artery Surgery study. Circulation 1982;66:16-23.
Mousavi S, Tosi J, Eskandarian R, et al. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain. J Gastroenterol Hepatol 2007;22:218-221.
Ford AC, Suares NC, Talley NJ. Meta-analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther 2011;34:172-180.
Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006;18:408-417.
Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
Richter JE, Bradley LA, Castell DO. Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med 1989;110:66-78.
Eslick GD, Talley NJ. Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust 2000;173:233-234.
Ruigómez A, Massó-González EL, Johansson S, et al. Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality. Br J Gen Pract 2009;59:e78-86.
Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-852.
Rao SS, Gregersen H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996;124:950-958.
Rao SS, Hayek B, Summers RW. Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction. Am J Gastroenterol 2001;96:2584-2589.
Nasr I, Attaluri A, Hashmi S, et al. Investigation of esophageal sensation and biomechanical properties in functional chest pain. Neurogastroenterol Motil 2010;22:520-526, e116.
Hoff DA, Gregersen H, Odegaard S, et al. Sensation evoked by esophageal distension in functional chest pain patients depends on mechanical stress rather than on ischemia. Neurogastroenterol Motil 2010;22:1170-1176, e1309-1111.
Borjesson M, Pilhall M, Eliasson T, et al. Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci 1998;43:1621-1628.
Fass R. Sensory testing of the esophagus. J Clin Gastroenterol 2004;38:628-641.
DeVault KR, Castell DO. Esophageal balloon distention and cerebral evoked potential recording in the evaluation of unexplained chest pain. Am J Med 1992;92:20S-26S.
Kamath MV, May A, Hollerbach S, et al. Effects of esophageal stimulation in patients with functional disorders of the gastrointestinal tract. Crit Rev Biomed Eng 2000;28:87-93.
Frobert O, Funch-Jensen P, Jacobsen NO, et al. Upper endoscopy in patients with angina and normal coronary angiograms. Endoscopy 1995;27:365-370.
Hobson AR, Furlong PL, Sarkar S, et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 2006;130:80-88.
Katz PO, Dalton CB, Richter JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med 1987;106:593-597.
Dekel R, Pearson T, Wendel C, et al. Assessment of oesophageal motor function in patients with dysphagia or chest pain—the Clinical Outcomes Research Initiative experience. Aliment Pharmacol Ther 2003;18:1083-1089.
Lam HG, Dekker W, Kan G, et al. Acute noncardiac chest pain in a coronary care unit. Evaluation by 24-hour pressure and pH recording of the esophagus. Gastroenterology 1992;102:453-460.
Fass R, Navarro-Rodriguez T. Noncardiac chest pain. J Clin Gastroenterol 2008;42:636-646.
Fass R. Chest pain of esophageal origin. Curr Opin Gastroenterol 2002;18:464-470.
Achem SR, Kolts BE, Wears R, et al. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol 1993;88:187-192.
DiMarino AJ, Jr., Allen ML, Lynn RB, et al. Clinical value of esophageal motility testing. Dig Dis 1998;16:198-204.
MacKenzie J, Belch J, Land D, et al. Oesophageal ischaemia in motility disorders associated with chest pain. Lancet 1988;2:592-595.
Liebermann-Meffert DM, Luescher U, Neff U, et al. Esophagectomy without thoracotomy: is there a risk of intramediastinal bleeding? A study on blood supply of the esophagus. Ann Surg 1987;206:184-192.
Holloway RH. Esophageal ultrasonography: A new view on esophageal motility. Am J Gastroenterol 2007;102:146-148.
Balaban DH, Yamamoto Y, Liu J, et al. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999;116:29-37.
Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001;281:G743-751.
Tougas G, Spaziani R, Hollerbach S, et al. Cardiac autonomic function and oesophageal acid sensitivity in patients with non-cardiac chest pain. Gut 2001;49:706-712.
Tougas G. The autonomic nervous system in functional bowel disorders. Gut 2000;47 Suppl 4:iv78-80; discussion iv87.
Kirchner A, Stefan H, Bastian K, et al. Vagus nerve stimulation suppresses pain but has limited effects on neurogenic inflammation in humans. Eur J Pain 2006;10:449-455.
Gibbs JF, Rajput A, Chadha KS, et al. The changing profile of esophageal cancer presentation and its implication for diagnosis. J Natl Med Assoc 2007;99:620-626.
Farmer AD, Coen SJ, Kano M, et al. Psychological traits influence autonomic nervous system recovery following esophageal intubation in health and functional chest pain. Neurogastroenterol Motil 2013;25:950-e772.
Demiryoguran NS, Karcioglu O, Topacoglu H, et al. Anxiety disorder in patients with non-specific chest pain in the emergency setting. Emerg Med J 2006;23:99-102.
Wong WM, Lam KF, Cheng C, et al. Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol 2004;10:707-712.
Kahrilas PJ. Nutcracker esophagus: an idea whose time has gone? Am J Gastroenterol 1993;88:167-169.
Perretta S, Fisichella PM, Galvani C, et al. Achalasia and chest pain: effect of laparoscopic Heller myotomy. J Gastrointest Surg 2003;7:595-598.
Bernstein LM, Baker LA. A clinical test for esophagitis. Gastroenterology 1958;34:760-781.
Mayou R, Bryant B, Forfar C, et al. Non-cardiac chest pain and benign palpitations in the cardiac clinic. Brit Heart J 1994;72:548-553.
Baylis JH, Kauntze R, Trounce JR. Observations on distension of the lower end of the oesophagus. Q J Med 1955;24:143-153.
Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics 2003;44:222-236.
Sengupta JN, Kauvar D, Goyal RK. Characteristics of vagal esophageal tension-sensitive afferent fibers in the opossum. J Neurophysiol 1989;61:1001-1010.
Humeau B, Cloarec D, Simon J, et al. Pseudo-angina pain of esophageal origin. Results of functional study and value of the balloon distention test. Gastroenterol Clin Biol 1990;14:334-341.
Goudot-Pernot C, Champigneulle B, Bigard MA, et al. A comparative prospective study of an edrophonium test and an esophageal balloon distension test in 78 patients with non-coronary angina and 12 healthy controls. Ann Gastroenterol Hepatol (Paris) 1991;27:41-48.
Guillebert G, Janssens J, Vantrappen G. Esophageal testing in 287 patients with noncardiac chest pain: The Leuven experience [abstract]. Gastroenterology 1995;108:A605.
Ghillebert G, Janssens J. Provocation tests versus 24-h pH and pressure measurements. Eur J Gastroenterol Hepatol 1995;7:1141-1146.
Fagring AJ, Gaston-Johansson F, Kjellgren KI, et al. Unexplained chest pain in relation to psychosocial factors and health-related quality of life in men and women. Eur J Cardiovasc Nurs 2007;6:329-336.
Stollman NH, Bierman PS, Ribeiro A, et al. CO2 provocation of panic: symptomatic and manometric evaluation in patients with noncardiac chest pain. Am J Gastroenterol 1997;92:839-842.
Wong WM, Lai KC, Lau CP, et al. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment Pharmacol Ther 2002;16:465-471.
Cooke RA, Anggiansah A, Wang J, et al. Hyperventilation and esophageal dysmotility in patients with noncardiac chest pain. Am J Gastroenterol 1996;91:480-484.
Richter J. Provacative tests in esophageal diseases. In: Scarpignato C, Galmiche JP, eds. Functional evaluation in esophageal diseases. Volume 22. Basel: Karger, 1994:188.
Canavan JB, Grainger RJ, Murray FE, et al. The diagnostic value of endoscopy in evaluating non-cardiac chest pain. Gastrointest Endosc 2005;61:AB128. #S1147.
Eken C, Oktay C, Bacanli A, et al. Anxiety and depressive disorders in patients presenting with chest pain to the emergency department: A comparison between cardiac and non-cardiac origin. J Emerg Med 2010;39:144-150.
Fass R, Pulliam G, Hayden CW. Patients with noncardiac chest pain (NCCP) receiving an empirical trial of high dose rabeprazole, demonstrate early symptom response—a double blind, placebo-controlled trial [abstract]. Gastroenterology 2001;129:A221.
Fass R, Fullerton H, Hayden CW, et al. Patients with noncardiac chest pain (NCCP) receiving an empirical trial of high dose rabeprazole, demonstrate early symptom response—a double blind, placebo--controlled trial [abstract]. Gastroenterology 2002;122:A-580-A-581. #W1175.
Eslick GD, Koloski NA, Talley NJ. Sexual, physical, verbal/emotional abuse and unexplained chest pain. Child Abuse Negl 2011;35:601-605.
Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004;109:568-572.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34.
Jerlock M, Kjellgren KI, Gaston-Johansson F, et al. Psychosocial profile in men and women with unexplained chest pain. J Intern Med 2008;264:265-274.
DeMeester TR, O'Sullivan GC, Bermudez G, et al. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg 1982;196:488-498.
Nevens F, Janssens J, Piessens J, et al. Prospective study on prevalence of esophageal chest pain in patients referred on an elective basis to a cardiac unit for suspected myocardial ischemia. Dig Dis Sci 1991;36:229-235.
Richter JE. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol 2000;30:S39-41.
Eslick GD. Usefulness of chest pain character and location as diagnostic indicators of an acute coronary syndrome. Am J Cardiol 2005;95:1228-1231.
Battaglia E, Bassotti G, Buonafede G, et al. Noncardiac chest pain of esophageal origin in patients with and without coronary artery disease. Hepatogastroenterology 2005;52:792-795.
Flook NW, Moayyedi P, Dent J, et al. Acid-suppressive therapy with esomeprazole for relief of unexplained chest pain in primary care: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2013;108:56-64.
Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-49.
Ofman JJ, Gralnek IM, Udani J, et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 1999;107:219-227.
Xia HH, Lai KC, Lam SK, et al. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther 2003;17:369-377.
Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol 2005;100:1226-1232.
Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain: a meta-analysis. Arch Intern Med 2005;165:1222-1228.
Fass R, Fennerty MB, Johnson C, et al. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol 1999;28:36-39.
Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006;101:1956-1963.
Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009;58:295-309.
Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006;101:446-452.
Hsia PC, Maher KA, Lewis JH, et al. Utility of upper endoscopy in the evaluation of noncardiac chest pain. Gastrointest Endosc 1991;37:22-26.
Garcia-Compean D, Gonzalez MV, Galindo G, et al. Prevalence of gastroesophageal reflux disease in patients with extraesophageal symptoms referred from otolaryngology, allergy, and cardiology practices: a prospective study. Dig Dis 2000;18:178-182.
Dickman R, Mattek N, Holub J, et al. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007;102:1173-1179.
Achem SR, Almansa C, Krishna M, et al. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther 2011;33:1194-1201.
Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology 1999;116:1300-1304.
Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol 2001;33:375-377.
Ghillebert G, Janssens J, Vantrappen G, et al. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990;31:738-744.
Deschner WK, Maher KA, Cattau Jr EL, et al. Intraesophageal balloon distention versus drug provocation in the evaluation of noncardiac chest pain. Am J Gastroenterol 1990;85:938-943.
Clouse RE, McCord GS, Lustman PJ, et al. Clinical correlates of abnormal sensitivity to intraesophageal balloon distension. Dig Dis Sci 1991;36:1040-1045.
de Caestecker JS, Pryde A, Heading RC. Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain. Gut 1992;33:580-586.
Gignoux C, Bost R, Hostein J, et al. Role of upper esophageal reflex and belch reflex dysfunctions in noncardiac chest pain. Dig Dis Sci 1993;38:1909-1914.
Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders—no pain no gain. Neurogastroenterol Motil 2014;26:603-610.
Sperber AD, Drossman DA. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther 2011;33:514-524.
Bradley LA, Scarinci IC, Richter JE. Pain threshold levels and coping strategies among patients who have chest pain and normal coronary arteries. Med Clin North Am 1991;75:1189-1202.
Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol 2012;52:6-17.
Sindrup SH, Otto M, Finnerup NB, et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 2005;96:399-409.
Mertz H, Fass R, Kodner A, et al. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-165.
Cannon RO, 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-1417.
Handa M, Mine K, Yamamoto H, et al. Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol 1999;28:228-232.
Prakash C, Clouse RE. Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999;44:2373-2379.
Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987;92:1027-1036.
Sarnelli G, Vandenberghe J, Tack J. Visceral hypersensitivity in functional disorders of the upper gastrointestinal tract. Dig Liver Dis 2004;36:371-376.
Broekaert D, Fischler B, Sifrim D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2006;23:365-370.
Varia I, Logue E, O'Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000;140:367-372.
Doraiswamy PM, Varia I, Hellegers C, et al. A randomized controlled trial of paroxetine for noncardiac chest pain. Psychopharmacol Bull 2006;39:15-24.
Spinhoven P, Van der Does AJ, Van Dijk E, et al. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine. J Psychosom Res 2010;69:227-235.
Lee H, Kim JH, Min BH, et al. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 2010;105:1504-1512.
Bueno L, Fioramonti J, Delvaux M, et al. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997;112:1714-1743.
Remes-Troche JM, Chahal P, Mudipalli R, et al. Adenosine modulates oesophageal sensorimotor function in humans. Gut 2009;58:1049-1055.
Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain. Circulation 1990;81:164-172.
Rao SS, Mudipalli RS, Mujica V, et al. An open-label trial of theophylline for functional chest pain. Dig Dis Sci 2002;47:2763-2768.
Rao SS, Mudipalli RS, Remes-Troche JM, et al. Theophylline improves esophageal chest pain—a randomized, placebo-controlled study. Am J Gastroenterol 2007;102:930-938.
Tack J, Sarnelli G. Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut 2002;51(Suppl 1):i77-i80.
Rodriguez-Stanley S, Zubaidi S, Proskin HM, et al. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity. Clin Gastroenterol Hepatol 2006;4:442-450.
Jones H, Cooper P, Miller V, et al. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006;55:1403-1408.
Chua YC, Ng KS, Sharma A, et al. Randomised clinical trial: pregabalin attenuates the development of acid-induced oesophageal hypersensitivity in healthy volunteers—a placebo-controlled study. Aliment Pharmacol Ther 2012;35:319-326.
Bradette M, Delvaux M, Staumont G, et al. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci 1994;39:1171-1178.
Schwetz I, Naliboff B, Munakata J, et al. Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:123-131.
Kirch S, Gegg R, Johns MM, et al. Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin. Ann Otol Rhinol Laryngol 2013;122:492-495.
Ockene IS, Shay MJ, Alpert JS, et al. Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med 1980;303:1249-1252.
Van Peski-Oosterbaan AS, Spinhoven P, Van der Does AJ, et al. Cognitive change following cognitive behavioural therapy for non-cardiac chest pain. Psychother Psychosom 1999;68:214-220.
Ryan M, Gevirtz R. Biofeedback-based psychophysiological treatment in a primary care setting: an initial feasibility study. Appl Psychophysiol Biofeedback 2004;29:79-93.
Kisely S, Campbell LA, Skerritt P. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev 2005:CD004101.
Potts SG, Bass CM. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study. Psychol Med 1995;25:339-347.
Ward BW, Wu WC, Richter JE, et al. Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful? Am J Gastroenterol 1987;82:215-218.
Wilhelmsen L, Rosengren A, Hagman M, et al. "Nonspecific" chest pain associated with high long-term mortality: results from the primary prevention study in Goteborg, Sweden. Clin Cardiol 1998;21:477-482.
Eslick GD, Talley NJ. Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil 2008;20:989-997.
Williams JF, Sontag SJ, Schnell T, et al. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease. Am J Gastroenterol 2009;104:2145-2152.
Tew R, Guthrie EA, Creed FH, et al. A long-term follow-up study of patients with ischaemic heart disease versus patients with nonspecific chest pain. J Psychosom Res 1995;39:977-985.
Gurevitz O, Jonas M, Boyko V, et al. Clinical profile and long-term prognosis of women < or = 50 years of age referred for coronary angiography for evaluation of chest pain. Am J Cardiol 2000;85:806-809.
Launbjerg J, Fruergaard P, Hesse B, et al. [The long-term prognosis of patients with acute chest pain of various origins]. Ugeskr Laeger 1997;159:175-179.
Kisely S, Guthrie E, Creed F, et al. Predictors of mortality and morbidity following admission with chest pain. J R Coll Physicians Lond 1997;31:177-183.
Karlson BW, Wiklund I, Bengtson A, et al. Prognosis, severity of symptoms, and aspects of well-being among patients in whom myocardial infarction was ruled out. Clin Cardiol 1994;17:427-431.
Hallani H, Eslick GD, Cox M, et al. Chest pain? Cause. Lancet 2004;363:452.
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
El-Serag HB. Epidemiology of non-erosive reflux disease. Digestion 2008;78 Suppl 1:6-10.
Dean BB, Gano AD Jr., Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004;2:656-664.
Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)—acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;17:537-545.
Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011;43:542-547.
Zerbib F, Belhocine K, Simon M, et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut 2012;61:501-506.
Frazzoni M, Conigliaro R, Mirante VG, et al. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil 2012;24:141-146.
Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398-1402.
Savarino E, Pohl D, Zentilin P, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut 2009;58:1185-1191.
Shapiro M, Simantov R, Yair M, et al. Comparison of central and intraesophageal factors between gastroesophageal reflux disease (GERD) patients and those with GERD-related noncardiac chest pain. Dis Esophagus 2012;25:702-708.
Lee SY, Lee KJ, Kim SJ, et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009;79:196-201.
Nojkov B, Rubenstein JH, Adlis SA, et al. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;27:473-482.
Jung HK, Halder S, McNally M, et al. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther 2007;26:453-461.
Surdea Blaga T, Dumitrascu D, Galmiche JP, et al. Functional heartburn: clinical characteristics and outcome. Eur J Gastroenterol Hepatol 2013;25:282-290.
Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 2012;61:1340-1354.
Fass R, Sontag SJ, Traxler B, et al. Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial. Clin Gastroenterol Hepatol 2006;4:50-56.
Dent J, Armstrong D, Delaney B, et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53(Suppl 4):iv1-24.
Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. Dig Liver Dis 2011;43:204-208.
Poh CH, Gasiorowska A, Navarro-Rodriguez T, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc 2010;71:28-34.
Sa CC, Kishi HS, Silva-Werneck AL, et al. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo) 2011;66:557-561.
Kandulski A, Jechorek D, Caro C, et al. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn. Aliment Pharmacol Ther 2013;38:643-651.
Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol 2013;48:473-482.
Vela MF, Craft BM, Sharma N, et al. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol 2011;106:844-850.
Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002;51:885-892.
Tobey NA, Hosseini SS, Argote CM, et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol 2004;99:13-22.
Tobey NA, Carson JL, Alkiek RA, et al. Dilated intercellular spaces: a morphological feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 1996;111:1200-1205.
Farre R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 2011;60:885-892.
Woodland P, Al-Zinaty M, Yazaki E, et al. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut 2013;62:1256-1261.
Yang M, Li ZS, Xu XR, et al. Characterization of cortical potentials evoked by oesophageal balloon distention and acid perfusion in patients with functional heartburn. Neurogastroenterol Motil 2006;18:292-299.
Kern MK, Birn RM, Jaradeh S, et al. Identification and characterization of cerebral cortical response to esophageal mucosal acid exposure and distention. Gastroenterology 1998;115:1353-1362.
Kern M, Hofmann C, Hyde J, et al. Characterization of the cerebral cortical representation of heartburn in GERD patients. Am J Physiol Gastrointest Liver Physiol 2004;286:G174-181.
Yang M, Li ZS, Chen DF, et al. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Clin J Pain 2010;26:326-331.
Fass R, Naliboff BD, Fass SS, et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology 2008;134:696-705.
Schey R, Dickman R, Parthasarathy S, et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007;133:1787-1795.
Naliboff BD, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med 2004;66:426-434.
Johnston BT, Lewis SA, Collins JS, et al. Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995;30:1-5.
Shapiro M, Green C, Bautista JM, et al. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol 2006;101:1084-1091.
Clouse RE, Richter J, Heading RC. Functional esophageal disorders. In: Corazziari E, Talley NJ, Thompson WG, et al., eds. Rome II – The functional gastrointestinal disorders (second edition). MacLean, VA: Degnon Associates, 2000:247-298.
Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006;116:254-260.
Park EY, Choi MG, Baeg M, et al. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease. Dig Dis Sci 2013;58:2933-2939.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-328; quiz 329.
Shaheen NJ, Weinberg DS, Denberg TD, et al. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med 2012;157:808-816.
Ponce J, Ortiz V, Maroto N, et al. High prevalence of heartburn and low acid sensitivity in patients with idiopathic achalasia. Dig Dis Sci 2011;56:773-776.
Richter JE. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 2007;4:658-664.
Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011[Epub ahead of print].
Frazzoni M, Piccoli M, Conigliaro R, et al. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc 2013;27:2940-2946.
Zerbib F, Roman S, Bruley Des Varannes S, et al. Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol 2013;11:366-372.
Viazis N, Keyoglou A, Kanellopoulos AK, et al. Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol 2012;107:1662-1667.
McDonald-Haile J, Bradley LA, Bailey MA, et al. Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease. Gastroenterology 1994;107:61-69.
Shapiro M, Shanani R, Taback H, et al. Functional chest pain responds to biofeedback treatment but functional heartburn does not: what is the difference? Eur J Gastroenterol Hepatol 2012;24:708-714.
Guarino MP, Cheng L, Ma J, et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil 2010;22:746-751, e219.
Krarup AL, Ny L, Astrand M, et al. Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther 2011;33:1113-1122.
Krarup AL, Ny L, Gunnarsson J, et al. Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain. Scand J Gastroenterol 2013;48:274-284.
Khajanchee YS, Hong D, Hansen PD, et al. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Am J Surg 2004;187:599-603.
Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 1999;3:292-300.
Bell RC, Hanna P, Brubaker S. Laparoscopic fundoplication for symptomatic but physiologic gastroesophageal reflux. J Gastrointest Surg 2001;5:462-467.
Broeders JA, Draaisma WA, Bredenoord AJ, et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg 2009;96:1023-1030.
Broeders JA, Draaisma WA, Bredenoord AJ, et al. Impact of symptom-reflux association analysis on long-term outcome after Nissen fundoplication. Br J Surg 2011;98:247-254.
Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci 2011;56:1099-1106.
Mainie I, Tutuian R, Agrawal A, et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006;93:1483-1487.
Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-979.
Kushnir VM, Sayuk GS, Gyawali CP. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring. Dig Dis Sci 2011;56:1412-1419.
Savarino E, Zentilin P, Tutuian R, et al. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol 2012;47:159-168.
Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol 2010;105:1053-1061.
Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008;103:2685-2693.
de Bortoli N, Martinucci I, Savarino E, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil 2014;26:28-35.
Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-527.
Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 2005;100:537-542.
Weijenborg PW, Cremonini F, Smout AJ, et al. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil 2012;24:747-757, e350.
Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol 2013;10:371-380.
Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - an update. J Neurogastroenterol Motil 2010;16:8-21.
Matthews PJ, Aziz Q, Facer P, et al. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol 2004;16:897-902.
Yoshida N, Kuroda M, Suzuki T, et al. Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease. Dig Dis Sci 2013;58:2237-2243.
Drewes AM, Babenko L, Birket-Smith L, et al. Induction of non-painful and painful intestinal sensations by hypertonic saline: a new human experimental model. Eur J Pain 2003;7:81-91.
Sarkar S, Aziz Q, Woolf CJ, et al. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000;356:1154-1159.
Sarkar S, Thompson DG, Woolf CJ, et al. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am J Gastroenterol 2004;99:1998-2006.
Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244-1252.
Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci U S A 2003;100:8538-8542.
Santos J, Yang PC, Soderholm JD, et al. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001;48:630-636.
Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006;101:453-459.
Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110:1982-1996.
Pandolfino JE, Vela MF. Esophageal-reflux monitoring. Gastrointest Endosc 2009;69:917-930, 930 e911.
Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003;98:740-749.
Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004;99:1037-1043.
Schey R, Shapiro M, Navarro-Rodriguez T, et al. Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol 2009;43:699-704.
Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-361.
Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741-1745.
Kushnir VM, Sathyamurthy A, Drapekin J, et al. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther 2012;35:1080-1087.
Patel A, Sayuk GS, Gyawali CP. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol 2014;109:836-844.
Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2014;13:884-891.
Kushnir VM, Prakash Gyawali C. High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain. Neurogastroenterol Motil 2011;23:1066-1072.
Broeders JA, Bredenoord AJ, Hazebroek EJ, et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut 2011;60:435-441.
Bredenoord AJ, Draaisma WA, Weusten BL, et al. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 2008;57:161-166.
Batch AJ. Globus pharyngeus (Part I). J Laryngol Otol 1988;102:152-158.
Deary IJ, Wilson JA, Harris MB, et al. Globus pharyngis: development of a symptom assessment scale. J Psychosom Res 1995;39:203-213.
Ravich WJ, Wilson RS, Jones B, et al. Psychogenic dysphagia and globus: reevaluation of 23 patients. Dysphagia 1989;4:35-38.
Timon C, O'Dwyer T, Cagney D, et al. Globus pharyngeus: long-term follow-up and prognostic factors. Ann Otol Rhinol Laryngol 1991;100:351-354.
Lee BE, Kim GH. Globus pharyngeus: a review of its etiology, diagnosis and treatment. World J Gastroenterol 2012;18:2462-2471.
Chevalier JM, Brossard E, Monnier P. Globus sensation and gastroesophageal reflux. Eur Arch Otorhinolaryngol 2003;260:273-276.
Hill J, Stuart RC, Fung HK, et al. Gastroesophageal reflux, motility disorders, and psychological profiles in the etiology of globus pharyngis. Laryngoscope 1997;107:1373-1377.
Wilson JA, Heading RC, Maran AG, et al. Globus sensation is not due to gastro-oesophageal reflux. Clin Otolaryngol Allied Sci 1987;12:271-275.
Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J 1982;126:46-48.
Malcomson KG. Globus hystericus vel pharyngis (a recommaissance of proximal vagal modalities). J Laryngol Otol 1968;82:219-230.
Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol Suppl 1989;156:7-13.
Tokashiki R, Yamaguchi H, Nakamura K, et al. Globus sensation caused by gastroesophageal reflux disease. Auris Nasus Larynx 2002;29:347-351.
Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1-78.
Meining A, Bajbouj M, Preeg M, et al. Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 2006;38:566-570.
Bajbouj M, Becker V, Eckel F, et al. Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology 2009;137:440-444.
Klare P, Meining A, von Delius S, et al. Argon plasma coagulation of gastric inlet patches for the treatment of globus sensation: it is an effective therapy in the long term. Digestion 2013;88:165-171.
Moloy PJ, Charter R. The globus symptom. Incidence, therapeutic response, and age and sex relationships. Arch Otolaryngol 1982;108:740-744.
Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991;26:73-81.
Rowley H, O'Dwyer TP, Jones AS, et al. The natural history of globus pharyngeus. Laryngoscope 1995;105:1118-1121.
Malcomson KG. Radiological findings in globus hystericus. Br J Radiol 1966;39:583-586.
Curtis DJ, Cruess DF, Berg T. The cricopharyngeal muscle: a videorecording review. AJR Am J Roentgenol 1984;142:497-500.
Clements JL, Jr., Cox GW, Torres WE, et al. Cervical esophageal webs—a roentgenanatomic correlation. Observations on the pharyngoesophagus. Am J Roentgenol Radium Ther Nucl Med 1974;121:221-231.
Maran A, Jacobson I. Cervical osteophytes presenting with pharyngeal symptoms. Laryngoscope 1971;81:412-417.
Agada FO, Coatesworth AP, Grace AR. Retroverted epiglottis presenting as a variant of globus pharyngeus. J Laryngol Otol 2007;121:390-392.
Mamede RC, De Mello-Filho FV, Dantas RO. Severe hypertrophy of the base of the tongue in adults. Otolaryngol Head Neck Surg 2004;131:378-382.
Quesada JL, Lorente J, Quesada P. Partial epiglottectomy as a possible treatment for globus pharyngeus? Eur Arch Otorhinolaryngol 2000;257:386-388.
Burns P, Timon C. Thyroid pathology and the globus symptom: are they related? A two year prospective trial. J Laryngol Otol 2007;121:242-245.
Chen CL, Szczesniak MM, Cook IJ. Evidence for oesophageal visceral hypersensitivity and aberrant symptom referral in patients with globus. Neurogastroenterol Motil 2009;21:1142-e1196.
Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia 1991;6:187-192.
Ott DJ, Ledbetter MS, Koufman JA, et al. Globus pharyngeus: radiographic evaluation and 24-hour pH monitoring of the pharynx and esophagus in 22 patients. Radiology 1994;191:95-97.
Corso MJ, Pursnani KG, Mohiuddin MA, et al. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci 1998;43:1513-1517.
Curran AJ, Barry MK, Callanan V, et al. A prospective study of acid reflux and globus pharyngeus using a modified symptom index. Clin Otolaryngol Allied Sci 1995;20:552-554.
Woo P, Noordzij P, Ross JA. Association of esophageal reflux and globus symptom: comparison of laryngoscopy and 24-hour pH manometry. Otolaryngol Head Neck Surg 1996;115:502-507.
Kibblewhite DJ, Morrison MD. A double-blind controlled study of the efficacy of cimetidine in the treatment of the cervical symptoms of gastroesophageal reflux. J Otolaryngol 1990;19:103-109.
Hori K, Kim Y, Sakurai J, et al. Non-erosive reflux disease rather than cervical inlet patch involves globus. J Gastroenterol 2010;45:1138-1145.
von Rahden BH, Stein HJ, Becker K, et al. Heterotopic gastric mucosa of the esophagus: literature-review and proposal of a clinicopathologic classification. Am J Gastroenterol 2004;99:543-551.
Moser G, Wenzel-Abatzi TA, Stelzeneder M, et al. Globus sensation: pharyngoesophageal function, psychometric and psychiatric findings, and follow-up in 88 patients. Arch Intern Med 1998;158:1365-1373.
Watson WC, Sullivan SN. Hypertonicity of the cricopharyngeal sphincter: A cause of globus sensation. Lancet 1974;2:1417-1419.
Cook IJ, Dent J, Collins SM. Upper esophageal sphincter tone and reactivity to stress in patients with a history of globus sensation. Dig Dis Sci 1989;34:672-676.
Cook IJ, Dent J, Shannon S, et al. Measurement of upper esophageal sphincter pressure. Effect of acute emotional stress. Gastroenterology 1987;93:526-532.
Kwiatek MA, Mirza F, Kahrilas PJ, et al. Hyperdynamic upper esophageal sphincter pressure: a manometric observation in patients reporting globus sensation. Am J Gastroenterol 2009;104:289-298.
Shaker R, Hogan WJ. Reflex-mediated enhancement of airway protective mechanisms. Am J Med 2000;108 Suppl 4a:8S-14S.
Babaei A, Bhargava V, Mittal RK. Upper esophageal sphincter during transient lower esophageal sphincter relaxation: effects of reflux content and posture. Am J Physiol Gastrointest Liver Physiol 2010;298:G601-607.
Moser G, Vacariu-Granser GV, Schneider C, et al. High incidence of esophageal motor disorders in consecutive patients with globus sensation. Gastroenterology 1991;101:1512-1521.
Leelamanit V, Geater A, Sinkitjaroenchai W. A study of 111 cases of globus hystericus. J Med Assoc Thai 1996;79:460-467.
Farkkila MA, Ertama L, Katila H, et al. Globus pharyngis, commonly associated with esophageal motility disorders. Am J Gastroenterol 1994;89:503-508.
Cook IJ, Shaker R, Dodd J, et al. Role of mechanical and chemical stimulation of the esophagus in globus sensation. Gastroenterology 1989;96:A99.
Puhakka H, Lehtinen V, Aalto T. Globus hystericus—a psychosomatic disease? J Laryngol Otol 1976;90:1021-1026.
Pratt LW, Tobin WH, Gallagher RA. Globus hystericus—office evaluation by phychological testing with the MMPI. Laryngoscope 1976;86:1540-1551.
Deary IJ, Smart A, Wilson JA. Depression and 'hassles' in globus pharyngis. Br J Psychiatry 1992;161:115-117.
Deary IJ, Wilson JA, Kelly SW. Globus pharyngis, personality, and psychological distress in the general population. Psychosomatics 1995;36:570-577.
Harris MB, Deary IJ, Wilson JA. Life events and difficulties in relation to the onset of globus pharyngis. J Psychosom Res 1996;40:603-615.
Harar RP, Kumar S, Saeed MA, et al. Management of globus pharyngeus: review of 699 cases. J Laryngol Otol 2004;118:522-527.
Cybulska EM. Globus hystericus—a somatic symptom of depression? The role of electroconvulsive therapy and antidepressants. Psychosom Med 1997;59:67-69.
Brown SR, Schwartz JM, Summergrad P, et al. Globus hystericus syndrome responsive to antidepressants. Am J Psychiatry 1986;143:917-918.
Khalil HS, Bridger MW, Hilton-Pierce M, et al. The use of speech therapy in the treatment of globus pharyngeus patients. A randomised controlled trial. Rev Laryngol Otol Rhinol (Bord) 2003;124:187-190.
Kwan AC, Bao T, Chakkaphak S, et al. Validation of Rome II criteria for functional gastrointestinal disorders by factor analysis of symptoms in Asian patient sample. J Gastroenterol Hepatol 2003;18:796-802.
Lind CD. Dysphagia: evaluation and treatment. Gastroenterol Clin North Am 2003;32:553-575.
Rosenstock A, Kushnir V, Patel A. Diagnostic yield in the evaluation of dysphagia. Gastrointest Endosc 2011;73:AB 287.
Gyawali CP, Bredenoord AJ, Conklin JL, et al. Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil 2013;25:99-133.
Bogte A, Bredenoord AJ, Oors J, et al. Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia. Neurogastroenterol Motil 2012;24:e364-372.
Deschner WK, Maher KA, Cattau EL Jr., et al. Manometric responses to balloon distention in patients with nonobstructive dysphagia. Gastroenterology 1989;97:1181-1185.
Roman S, Kahrilas PJ. Challenges in the swallowing mechanism: nonobstructive dysphagia in the era of high-resolution manometry and impedance. Gastroenterol Clin North Am 2011;40:823-835, ix-x.
Pandolfino JE, Roman S, Carlson D, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology 2011;141:469-475.
Jung HY, Puckett JL, Bhalla V, et al. Asynchrony between the circular and the longitudinal muscle contraction in patients with nutcracker esophagus. Gastroenterology 2005;128:1179-1186.
Fox M, Sweis R. Future directions in esophageal motility and function – new technology and methodology. Neurogastroenterol Motil 2012;24 Suppl 1:48-56.
Roman S, Lin Z, Kwiatek MA, et al. Weak peristalsis in esophageal pressure topography: classification and association with dysphagia. Am J Gastroenterol 2011;106:349-356.
Hoshino M, Sundaram A, Srinivasan A, et al. The relationship between dysphagia, pump function, and lower esophageal sphincter pressures on high-resolution manometry. J Gastrointest Surg 2012;16:495-502.
Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988;94:73-80.
Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol 2004;2:230-236.
Savarino E, Gemignani L, Pohl D, et al. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011;34:476-486.
Daum C, Sweis R, Kaufman E, et al. Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease. Neurogastroenterol Motil 2011;23:517-e200.
Jacob P, Kahrilas PJ, Vanagunas A. Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci 1990;35:939-942.
Triadafilopoulos G. Nonobstructive dysphagia in reflux esophagitis. Am J Gastroenterol 1989;84:614-618.
Bulsiewicz WJ, Kahrilas PJ, Kwiatek MA, et al. Esophageal pressure topography criteria indicative of incomplete bolus clearance: a study using high-resolution impedance manometry. Am J Gastroenterol 2009;104:2721-2728.
Bohn B, Bonaz B, Gueddah N, et al. Oesophageal motor and sensitivity abnormalities in non-obstructive dysphagia. Eur J Gastroenterol Hepatol 2002;14:271-277.
Howard PJ, Maher L, Pryde A. Esophageal motor patterns during episodes of dysphagia for solids. J Gastroenterol Motil 1991;3:123-130.
Bogte A, Bredenoord AJ, Oors J, et al. Sensation of stasis is poorly correlated with impaired esophageal bolus transport. Neurogastroenterol Motil 2013;26:538-545.
Pouderoux P, Shi G, Tatum RP, et al. Esophageal solid bolus transit: studies using concurrent videofluoroscopy and manometry. Am J Gastroenterol 1999;94:1457-1463.
Lee H, Lee SK, Park JC, et al. Effect of acid swallowing on esophageal contraction in patients with heartburn related to hypersensitivity. J Gastroenterol Hepatol 2013;28:84-89.
Nasr I, Attaluri A, Coss-Adame E, et al. Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain. Aliment Pharmacol Ther 2012;35:1474-1481.
Szczesniak MM, Fuentealba SE, Cook IJ. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum. Clin J Pain 2013;29:70-77.
Barofsky I, Fontaine KR. Do psychogenic dysphagia patients have an eating disorder? Dysphagia 1998;13:24-27.
Clouse RE, Carney RM. The psychological profile of non-cardiac chest pain patients. Eur J Gastroenterol Hepatol 1995;7:1160-1165.
Stacher G, Schmierer G, Landgraf M. Tertiary esophageal contractions evoked by acoustical stimuli. Gastroenterology 1979;77:49-54.
Dellon ES, Jensen ET, Martin CF, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 2013;12:589-596.
van Westen D, Eckberg O. Solid bolus swallowing in the radiologic evaluation of dysphagia. Acta Radiol 1993;34:372-375.
Pandolfino JE, Kwiatek MA, Ho K, et al. Unique features of esophagogastric junction pressure topography in hiatus hernia patients with dysphagia. Surgery 2010;147:57-64.
Cordier L, Bohn B, Bonaz B, et al. Evaluation of esophageal motility disorders triggered by ingestion of solids in the case of non-obstructive dysphagia. Gastroenterol Clin Biol 1999;23:200-206.
Kushnir V, Sayuk GS, Gyawali CP. Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry. Neurogastroenterol Motil 2012;24:1069-e1561.
Nicodeme F, Hirano I, Chen J, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2013;11:1101-1107, e1101.
Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology 1994;107:1865-1884.
Colon VJ, Young MA, Ramirez FC. The short- and long-term efficacy of empirical esophageal dilation in patients with nonobstructive dysphagia: a prospective, randomized study. Am J Gastroenterol 2000;95:910-913.
Porter RF, Kumar N, Drapekin JE, et al. Fragmented esophageal smooth muscle contraction segments on high resolution manometry: a marker of esophageal hypomotility. Neurogastroenterol Motil 2012;24:763-768, e353.
Xiao Y, Kahrilas PJ, Nicodeme F, et al. Lack of correlation between HRM metrics and symptoms during the manometric protocol. Am J Gastroenterol 2014;109:521-526.
Smout A, Fox M. Weak and absent peristalsis. Neurogastroenterol Motil 2012;24(Suppl 1):40-47.
Lavu K, Mathew TP, Minocha A. Effectiveness of esophageal dilation in relieving nonobstructive esophageal dysphagia and improving quality of life. South Med J 2004;97:137-140.
Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol 2004;2:665-668.
Coss-Adame E, Erdogan A, Rao SS. Treatment of esophageal (noncardiac) chest pain: A review. Clin Gastroenterol Hepatol 2013;12:1224-1245.
Nguyen TM, Eslick GD. Systematic review: the treatment of noncardiac chest pain with antidepressants. Aliment Pharmacol Ther 2012;35:493-500.
Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998;42:807-813.
Naini P, Dutta SK, Karhadkar AS, et al. Critical evaluation of esophageal dilation in nonobstructive dysphagia with and without esophageal rings. J Clin Gastroenterol 2007;41:362-365.
Winters C, Artnak EJ, Benjamin SB, et al. Esophageal bougienage in symptomatic patients with the nutcracker esophagus. A primary esophageal motility disorder. JAMA 1984;252:363-366.
Scolapio JS, Gostout CJ, Schroeder KW, et al. Dysphagia without endoscopically evident disease: to dilate or not? Am J Gastroenterol 2001;96:327-330.
Vanuytsel T, Bisschops R, Farre R, et al. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013;11:1115-1121 e1112.
Storr M, Allescher HD, Rosch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injection of botulinum toxin: a prospective study with long term follow-up. Gastrointest Endosc 2001;54:18A.

You must be logged in with a subscription to access this page. Click here to login.